{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T11:06:26Z","timestamp":1791111986542,"version":"4.1.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2004,2]]},"DOI":"10.1016\/s0145-2126(03)00183-8","type":"journal-article","created":{"date-parts":[[2003,8,8]],"date-time":"2003-08-08T04:49:55Z","timestamp":1060318195000},"page":"179-190","source":"Crossref","is-referenced-by-count":73,"title":["Increased cyclooxygenase-2 (COX-2): a potential role in the pathogenesis of lymphoma"],"prefix":"10.1016","volume":"28","author":[{"given":"Ted","family":"Wun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayes","family":"McKnight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph M","family":"Tuscano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S0145-2126(03)00183-8_BIB1","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1093\/jnci\/90.20.1529","article-title":"Cyclooxygenase-2 inhibitors in tumorigenesis (Part I)","volume":"90","author":"Taketo","year":"1998","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/S0145-2126(03)00183-8_BIB2","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S1357-2725(98)00152-6","article-title":"Cyclooxygenase-1 and cyclooxygenase-2 isoenzymes","volume":"31","author":"Hla","year":"1999","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/S0145-2126(03)00183-8_BIB3","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1080\/10408360091174286","article-title":"Biochemistry of cyclooxygenase (COX)-2 inhibitors and molecular pathology of COX-2 in neoplasia","volume":"37","author":"Fosslien","year":"2000","journal-title":"Crit Rev. Clin. Lab Sci."},{"key":"10.1016\/S0145-2126(03)00183-8_BIB4","doi-asserted-by":"crossref","first-page":"33157","DOI":"10.1074\/jbc.271.17.9906","article-title":"Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2","volume":"271","author":"Smith","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0145-2126(03)00183-8_BIB5","doi-asserted-by":"crossref","first-page":"4816","DOI":"10.1073\/pnas.93.10.4816","article-title":"Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect","volume":"93","author":"Kutchera","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/S0145-2126(03)00183-8_BIB6","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/0016-5085(94)90246-1","article-title":"Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas","volume":"107","author":"Eberhart","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/S0145-2126(03)00183-8_BIB7","first-page":"2556","article-title":"Expression of prostaglandin G\/H synthase-1 and -2 protein in human colon cancer","volume":"55","author":"Kargman","year":"1995","journal-title":"Cancer Res."},{"key":"10.1016\/S0145-2126(03)00183-8_BIB8","first-page":"3785","article-title":"Expression of cyclooxygenase-1 and -2 in human colorectal cancer","volume":"55","author":"Sano","year":"1995","journal-title":"Cancer Res."},{"key":"10.1016\/S0145-2126(03)00183-8_BIB9","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/jnci\/90.6.455","article-title":"Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer","volume":"90","author":"Hwang","year":"1998","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/S0145-2126(03)00183-8_BIB10","first-page":"198","article-title":"Cyclooxygenase-2 expression in human esophageal carcinoma","volume":"59","author":"Zimmermann","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/S0145-2126(03)00183-8_BIB11","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0092-8674(00)81988-1","article-title":"Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)","volume":"87","author":"Oshima","year":"1996","journal-title":"Cell"},{"issue":"Suppl 2","key":"10.1016\/S0145-2126(03)00183-8_BIB12","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1007\/s000110050295","article-title":"COX-2 and colon cancer","volume":"47","author":"Taketo","year":"1998","journal-title":"Inflamm. Res."},{"key":"10.1016\/S0145-2126(03)00183-8_BIB13","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0092-8674(95)90127-2","article-title":"Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2","volume":"83","author":"Tsujii","year":"1995","journal-title":"Cell"},{"key":"10.1016\/S0145-2126(03)00183-8_BIB14","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1349-7006.1997.tb00424.x","article-title":"Apoptosis induced by NS-398, a selective cyclooxygenase-2 inhibitor, in human colorectal cancer cell lines","volume":"88","author":"Hara","year":"1997","journal-title":"Jpn. J. Cancer Res."},{"key":"10.1016\/S0145-2126(03)00183-8_BIB15","first-page":"362","article-title":"Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells","volume":"58","author":"Sheng","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/S0145-2126(03)00183-8_BIB16","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1006\/jsre.1998.5511","article-title":"The effect of selective cyclooxygenase inhibitors on intestinal epithelial cell mitogenesis","volume":"81","author":"Erickson","year":"1999","journal-title":"J. Surg. Res."},{"key":"10.1016\/S0145-2126(03)00183-8_BIB17","first-page":"G1061","article-title":"Cyclooxygenase-2 inhibitors suppress the growth of gastric cancer xenografts via induction of apoptosis in nude mice","volume":"274","author":"Sawaoka","year":"1998","journal-title":"Am. J. Physiol."},{"key":"10.1016\/S0145-2126(03)00183-8_BIB18","first-page":"4245","article-title":"NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells","volume":"58","author":"Liu","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/S0145-2126(03)00183-8_BIB19","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1073\/pnas.95.2.681","article-title":"Mechanisms underlying nonsteroidal anti-inflammatory drug-mediated apoptosis","volume":"95","author":"Chan","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/S0145-2126(03)00183-8_BIB20","doi-asserted-by":"crossref","first-page":"51S","DOI":"10.1016\/S0002-9343(99)00117-5","article-title":"The clinical potential of cyclooxygenase-2-specific inhibitors","volume":"106","author":"Lipsky","year":"1999","journal-title":"Am. J. Med."},{"key":"10.1016\/S0145-2126(03)00183-8_BIB21","doi-asserted-by":"crossref","first-page":"11397","DOI":"10.1074\/jbc.275.15.11397","article-title":"The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2","volume":"275","author":"Hsu","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0145-2126(03)00183-8_BIB22","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1200\/JCO.1998.16.8.2780","article-title":"New approach to classifying non-Hodgkin\u2019s lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin\u2019s Lymphoma Classification Project","volume":"16","author":"Armitage","year":"1998","journal-title":"J. Clin. Oncol."},{"issue":"Suppl 1","key":"10.1016\/S0145-2126(03)00183-8_BIB23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1023\/A:1008383406103","article-title":"Lymphoma classification\u2014from controversy to consensus: the R.E.A.L. and WHO Classification of lymphoid neoplasms","volume":"11","author":"Harris","year":"2000","journal-title":"Ann. Oncol."},{"key":"10.1016\/S0145-2126(03)00183-8_BIB24","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0037-1963(00)90019-2","article-title":"Recurring chromosomal abnormalities in non-Hodgkin\u2019s lymphoma: biologic and clinical significance","volume":"37","author":"Chaganti","year":"2000","journal-title":"Semin. Hematol."},{"key":"10.1016\/S0145-2126(03)00183-8_BIB25","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/00001622-199909000-00006","article-title":"Recent advances in the molecular pathogenesis of lymphomas","volume":"11","author":"Sarris","year":"1999","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/S0145-2126(03)00183-8_BIB26","first-page":"F634","article-title":"Interleukin-1\u03b2 activates c-jun NH2-terminal kinase subgroup of mitogen-activated protein kinases in mesangial cells","volume":"270","author":"Guan","year":"1996","journal-title":"Am. J. Physiol."},{"key":"10.1016\/S0145-2126(03)00183-8_BIB27","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000206188","article-title":"Increased prostaglandin E production in malignant lymphomas","volume":"74","author":"Sebahoun","year":"1985","journal-title":"Acta Haematol."},{"key":"10.1016\/S0145-2126(03)00183-8_BIB28","first-page":"293","article-title":"Expression of cyclooxygenase-2 and prostaglandins by B-1 cells and B-CLL cells","volume":"252","author":"Phipps","year":"2000","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/S0145-2126(03)00183-8_BIB29","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1084\/jem.161.5.996","article-title":"Inhibition of plasmacytoma development in BALB\/c mice by indomethacin","volume":"161","author":"Potter","year":"1985","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0145-2126(03)00183-8_BIB30","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1182\/blood.V90.1.260","article-title":"Indomethacin is a potent inhibitor of pristane and plastic disc induced plasmacytomagenesis in a hypersusceptible BALB\/c congenic strain","volume":"90","author":"Potter","year":"1997","journal-title":"Blood"},{"key":"10.1016\/S0145-2126(03)00183-8_BIB31","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1182\/blood.V94.4.1382","article-title":"CD22 cross-linking generates B-cell antigen receptor-independent signals that activate the JNK\/SAPK signaling cascade","volume":"94","author":"Tuscano","year":"1999","journal-title":"Blood"},{"key":"10.1016\/S0145-2126(03)00183-8_BIB32","doi-asserted-by":"crossref","first-page":"C72","DOI":"10.1152\/ajpcell.1998.274.1.C72","article-title":"Post-translational regulation of cyclooxygenase by tyrosine phosphorylation in cerebral endothelial cells","volume":"274","author":"Parfenova","year":"1998","journal-title":"Am. J. Physiol."},{"issue":"52","key":"10.1016\/S0145-2126(03)00183-8_BIB33","doi-asserted-by":"crossref","first-page":"48997","DOI":"10.1074\/jbc.M107829200","article-title":"Cyclooxygenase-2 inducing Mcl-1-dependent survival mechanism in human lung adenocarcinoma CL1.0 cells. Involvement of phosphatidylinositol 3-kinase\/Akt pathway","volume":"276","author":"Lin","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/S0145-2126(03)00183-8_BIB34","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s004320000225","article-title":"Cyclooxygenase-2: a novel target for cancer chemotherapy?","volume":"127","author":"Dempke","year":"2001","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/S0145-2126(03)00183-8_BIB35","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev.iy.13.040195.002501","article-title":"Regulation of lymphocyte survival by the bcl-2 gene family","volume":"13","author":"Cory","year":"1995","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/S0145-2126(03)00183-8_BIB36","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/369156a0","article-title":"The stress-activated protein kinase subfamily of c-Jun kinases","volume":"369","author":"Kyriakis","year":"1994","journal-title":"Nature"},{"key":"10.1016\/S0145-2126(03)00183-8_BIB37","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1074\/jbc.271.2.631","article-title":"Persistent activation of c-Jun N-terminal kinase 1 (JNK1) in \u03b3 radiation-induced apoptosis","volume":"271","author":"Chen","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0145-2126(03)00183-8_BIB38","unstructured":"Shi, C-S, Kehrl, JH. Activation of SAPK\/JNK but not NF-\u03baB, by the TNF receptor 1 through a TRAF-2 and CGKR-dependent pathway, 2001."},{"key":"10.1016\/S0145-2126(03)00183-8_BIB39","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/j.1460-2075.1996.tb00337.x","article-title":"Cross-linking CD40 on B cells preferentially induces stress-activated protein kinases rather than mitogen-activated protein kinases","volume":"15","author":"Berberich","year":"1996","journal-title":"EMBO J."},{"key":"10.1016\/S0145-2126(03)00183-8_BIB40","doi-asserted-by":"crossref","first-page":"12901","DOI":"10.1074\/jbc.273.21.12901","article-title":"Induction of cyclooxygenase-2 by the activated MEKK1 \u2192 SEK1\/MKK4 \u2192 p38 mitogen-activated protein kinase pathway","volume":"273","author":"Guan","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0145-2126(03)00183-8_BIB41","doi-asserted-by":"crossref","first-page":"8083","DOI":"10.1074\/jbc.272.12.8083","article-title":"p38 Mitogen-activated protein kinase down-regulates nitric oxide and up-regulates prostaglandin E2 biosynthesis stimulated by interleukin-1\u03b2","volume":"272","author":"Guan","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0145-2126(03)00183-8_BIB42","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0167-5699(91)90064-Z","article-title":"A new view of prostaglandin E regulation of the immune response","volume":"12","author":"Phipps","year":"1991","journal-title":"Immunol. Today"},{"key":"10.1016\/S0145-2126(03)00183-8_BIB43","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4049\/jimmunol.154.1.162","article-title":"Prostaglandin E2 promotes B lymphocyte Ig isotype switching to IgE","volume":"154","author":"Roper","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/S0145-2126(03)00183-8_BIB44","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.4049\/jimmunol.149.9.2984","article-title":"Prostaglandin E2 and cAMP inhibit B lymphocyte activation and simultaneously promote IgE and IgG1 synthesis","volume":"149","author":"Roper","year":"1992","journal-title":"J. Immunol."},{"key":"10.1016\/S0145-2126(03)00183-8_BIB45","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.4049\/jimmunol.148.12.3943","article-title":"Anti-class II antibodies potentiate IgG2a production by lipopolysaccharide-stimulated B lymphocytes treated with prostaglandin E2 and IFN-\u03b3","volume":"148","author":"Stein","year":"1992","journal-title":"J. Immunol."},{"key":"10.1016\/S0145-2126(03)00183-8_BIB46","doi-asserted-by":"crossref","first-page":"11784","DOI":"10.1074\/jbc.275.16.11784","article-title":"Xenobiotic-metabolizing cytochromes P450 convert prostaglandin endoperoxide to hydroxyheptadecatrienoic acid and the mutagen, malondialdehyde","volume":"275","author":"Plastaras","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0145-2126(03)00183-8_BIB47","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1182\/blood.V76.4.655.655","article-title":"Inflammation and cancer: role of phagocyte-generated oxidants in carcinogenesis","volume":"76","author":"Weitzman","year":"1990","journal-title":"Blood"},{"key":"10.1016\/S0145-2126(03)00183-8_BIB48","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0092-8674(00)81433-6","article-title":"Cyclooxygenase regulates angiogenesis induced by colon cancer cells","volume":"93","author":"Tsujii","year":"1998","journal-title":"Cell"},{"key":"10.1016\/S0145-2126(03)00183-8_BIB49","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1172\/JCI9621","article-title":"Host cyclooxygenase-2 modulates carcinoma growth","volume":"105","author":"Williams","year":"2000","journal-title":"J. Clin. Invest"},{"key":"10.1016\/S0145-2126(03)00183-8_BIB50","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1749-6632.1997.tb48606.x","article-title":"Cyclooxygenase-2 gene expression is upregulated in transformed mammary epithelial cells","volume":"833","author":"Subbaramaiah","year":"1997","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/S0145-2126(03)00183-8_BIB51","first-page":"429","article-title":"Cyclooxygenase-2 is overexpressed in human cervical cancer","volume":"7","author":"Kulkarni","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/S0145-2126(03)00183-8_BIB52","first-page":"1572","article-title":"Transcriptional activation of cyclooxygenase-2 in Wnt-1-transformed mouse mammary epithelial cells","volume":"59","author":"Howe","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/S0145-2126(03)00183-8_BIB53","first-page":"4424","article-title":"Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells","volume":"56","author":"Subbaramaiah","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/S0145-2126(03)00183-8_BIB54","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0005-2760(95)00194-8","article-title":"Prostaglandin synthase 2","volume":"1299","author":"Herschman","year":"1996","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/S0145-2126(03)00183-8_BIB55","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/978-1-4899-1813-0_9","article-title":"Function and regulation of prostaglandin synthase-2","volume":"407","author":"Herschman","year":"1997","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/S0145-2126(03)00183-8_BIB56","first-page":"3","article-title":"Molecular pathology of cyclooxygenase-2 in neoplasia","volume":"30","author":"Fosslien","year":"2000","journal-title":"Ann. Clin. Lab Sci."},{"key":"10.1016\/S0145-2126(03)00183-8_BIB57","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s11912-001-0058-8","article-title":"New drug development in non-Hodgkin lymphomas","volume":"3","author":"Cheson","year":"2001","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/S0145-2126(03)00183-8_BIB58","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0037-1963(00)90055-6","article-title":"Apoptosis and cancer: strategies for integrating programmed cell death","volume":"37","author":"Reed","year":"2000","journal-title":"Semin. Hematol."},{"key":"10.1016\/S0145-2126(03)00183-8_BIB59","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/028418600430707","article-title":"Apoptosis and the pathogenesis of lymphoma","volume":"39","author":"Voutsadakis","year":"2000","journal-title":"Acta Oncol."},{"key":"10.1016\/S0145-2126(03)00183-8_BIB60","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/carcin\/22.1.17","article-title":"Growth inhibition and induction of apoptosis in colorectal tumor cells by cyclooxygenase inhibitors","volume":"22","author":"Richter","year":"2001","journal-title":"Carcinogenesis"},{"key":"10.1016\/S0145-2126(03)00183-8_BIB61","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0022-5347(05)67321-1","article-title":"Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo","volume":"164","author":"Liu","year":"2000","journal-title":"J. Urol."},{"key":"10.1016\/S0145-2126(03)00183-8_BIB62","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000030005","article-title":"High-grade malignant non-Hodgkin\u2019s lymphomas differ from low-grade lymphomas in the extent of apoptosis and their expression of bcl-2, mcl-1, bax and p53","volume":"19","author":"Soini","year":"1998","journal-title":"Tumor Biol."},{"key":"10.1016\/S0145-2126(03)00183-8_BIB63","first-page":"177","article-title":"Immunodetection of apoptosis-regulating proteins in lymphomas from patients with and without human immunodeficiency virus infection","volume":"149","author":"Schlaifer","year":"1996","journal-title":"Am. J. Pathol."},{"key":"10.1016\/S0145-2126(03)00183-8_BIB64","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1056\/NEJM200006293422603","article-title":"The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis","volume":"342","author":"Steinbach","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/S0145-2126(03)00183-8_BIB65","first-page":"1377","article-title":"Chemotherapeutic evaluation of celecoxib, a cyclooxygenase-2 inhibitor, in a rat mammary tumor model","volume":"7","author":"Alshafie","year":"2000","journal-title":"Oncol. Rep."},{"key":"10.1016\/S0145-2126(03)00183-8_BIB66","first-page":"2101","article-title":"Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor","volume":"60","author":"Harris","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/S0145-2126(03)00183-8_BIB67","first-page":"409","article-title":"Enhanced antitumor activity by co-administration of celecoxib and the chemotherapeutic agents cyclophosphamide and 5-FU","volume":"41","author":"Moore","year":"2000","journal-title":"Proc Am Association Cancer Res"},{"key":"10.1016\/S0145-2126(03)00183-8_BIB68","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1093\/jnci\/91.17.1501","article-title":"Enhancement of tumor response to gamma-radiation by an inhibitor of cyclooxygenase-2 enzyme","volume":"91","author":"Milas","year":"1999","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/S0145-2126(03)00183-8_BIB69","first-page":"1326","article-title":"Preferential enhancement of tumor radioresponse by a cyclooxygenase-2 inhibitor","volume":"60","author":"Kishi","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/S0145-2126(03)00183-8_BIB70","first-page":"3178","article-title":"Chronotherapy and chronotoxicity of the cyclooxygenase-2 inhibitor, celecoxib, in athymic mice bearing human breast cancer xenografts","volume":"7","author":"Blumenthal","year":"2001","journal-title":"Clin. Cancer Res."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212603001838?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212603001838?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T19:42:29Z","timestamp":1682538149000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212603001838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":70,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,2]]}},"alternative-id":["S0145212603001838"],"URL":"https:\/\/doi.org\/10.1016\/s0145-2126(03)00183-8","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2004,2]]}}}